Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. TheStreet Ratings quantitative algorithm...
IRIDEX Corporation (Nasdaq: IRIX) announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 -...
IRIDEX Corporation (NASDAQ:IRIX)
Q2 2014 Earnings Conference Call
July 31, 2014 05:00 p.m. ET
William M. Moore – Interim President and CEO
James H. Mackaness – Chief Financial Officer and Chief Operating Officer
IRIDEX Corporation (IRIX)
Q1 2014 Earnings Conference Call
May 1, 2014 17:00 ET
Will Moore - Chief Executive Officer
Jim Mackaness - Chief Financial Officer and Chief Operating Officer
Susan Bruce - Investor Relations
Q4 2013 Earnings Call
February 27, 2014 5:00 pm ET
William M. Moore - Chairman, Chief Executive Officer and President
James H. Mackaness - Chief Financial Officer, Chief Operating Officer and...
By Inflection Point Investing LLC:
Under-followed by the Street and unknown to most investors, ophthalmology pure-play, Iridex Corp. (IRIX), is both a compelling short-term and long-term investment opportunity. Buttressed by its sterling...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it has received the final $510,000 cash payment from the February 2012 sale of its aesthetic business unit. The cash was released to IRIDEX from an escrow account set up as part of the...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to IRIDEX (IRIX):